CA2336712A1 - Transdermal plaster containing at least one active ingredient which influences blood serum lipid levels - Google Patents

Transdermal plaster containing at least one active ingredient which influences blood serum lipid levels Download PDF

Info

Publication number
CA2336712A1
CA2336712A1 CA002336712A CA2336712A CA2336712A1 CA 2336712 A1 CA2336712 A1 CA 2336712A1 CA 002336712 A CA002336712 A CA 002336712A CA 2336712 A CA2336712 A CA 2336712A CA 2336712 A1 CA2336712 A1 CA 2336712A1
Authority
CA
Canada
Prior art keywords
active ingredient
blood serum
lipid levels
serum lipid
plaster containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002336712A
Other languages
French (fr)
Other versions
CA2336712C (en
Inventor
Achim Berthold
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LTS Lohmann Therapie Systeme AG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2336712A1 publication Critical patent/CA2336712A1/en
Application granted granted Critical
Publication of CA2336712C publication Critical patent/CA2336712C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A preparation containing at least one active substance having an influence on the lipid blood levels of an organism is characterized in that it is present in the form of a transdermal therapeutic patch containing the active substance in a self-adhesive matrix layer which can be covered at the side facing away from the skin with an active substance--impermeable backing layer
CA002336712A 1998-07-09 1999-07-07 Transdermal plaster containing at least one active ingredient which influences blood serum lipid levels Expired - Lifetime CA2336712C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19830732A DE19830732B4 (en) 1998-07-09 1998-07-09 Composition containing at least one substance influencing blood lipid levels and its use
DE19830732.2 1998-07-09
PCT/EP1999/004757 WO2000002541A1 (en) 1998-07-09 1999-07-07 Transdermal plaster containing at least one active ingredient which influences blood serum lipid levels

Publications (2)

Publication Number Publication Date
CA2336712A1 true CA2336712A1 (en) 2000-01-20
CA2336712C CA2336712C (en) 2008-09-09

Family

ID=7873488

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002336712A Expired - Lifetime CA2336712C (en) 1998-07-09 1999-07-07 Transdermal plaster containing at least one active ingredient which influences blood serum lipid levels

Country Status (22)

Country Link
EP (1) EP1094797B1 (en)
JP (1) JP2002520272A (en)
KR (1) KR100549848B1 (en)
CN (1) CN1309377C (en)
AR (1) AR019902A1 (en)
AT (1) ATE278395T1 (en)
AU (1) AU770573B2 (en)
BR (1) BR9911941A (en)
CA (1) CA2336712C (en)
CZ (1) CZ300976B6 (en)
DE (2) DE19830732B4 (en)
ES (1) ES2230872T3 (en)
HU (1) HU226614B1 (en)
IL (2) IL140667A0 (en)
MX (1) MXPA01000126A (en)
NZ (1) NZ509215A (en)
PL (1) PL194983B1 (en)
RU (1) RU2227023C2 (en)
TR (1) TR200100021T2 (en)
TW (1) TWI237572B (en)
WO (1) WO2000002541A1 (en)
ZA (1) ZA200100171B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8173155B2 (en) 2004-06-01 2012-05-08 Hisamitsu Pharmaceutical Co., Inc. Adhesive patch

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL189890B1 (en) * 1999-09-14 2005-10-31 Kazmierski Jan Zaklad Prod Usl Preparation for protecting plants against diseases
WO2004026297A1 (en) * 2002-09-20 2004-04-01 Kowa Co., Ltd. Preparation for external use
US9173836B2 (en) 2003-01-02 2015-11-03 FemmeParma Holding Company, Inc. Pharmaceutical preparations for treatments of diseases and disorders of the breast
MXPA05007266A (en) * 2003-01-02 2006-01-17 Femmepharma Holding Co Inc Pharmaceutical preparations for treatments of diseases and disorders of the breast.
JPWO2005094814A1 (en) * 2004-03-31 2008-02-14 興和株式会社 Topical preparation
JP4986411B2 (en) * 2004-06-01 2012-07-25 久光製薬株式会社 Patch
US20050281868A1 (en) * 2004-06-21 2005-12-22 Fairfield Clinical Trials, Llc Transdermal delivery system for statin combination therapy
DE102004062182B4 (en) * 2004-12-20 2007-06-06 Bayer Schering Pharma Ag Transdermal patch with progesterone A-specific ligands (PRASL) as active ingredient
EP1996118A4 (en) * 2006-03-07 2013-03-06 Osteoscreen Ip Llc Hmg co-a reductase inhibitor enhancement of bone and cartilage
KR100817274B1 (en) * 2006-08-21 2008-03-27 삼성전기주식회사 Light emitting diode package and method of manufacturing the same
WO2018115535A1 (en) 2016-12-19 2018-06-28 Nutritape, S.L. Energising patch for sportspeople
US11884598B2 (en) 2019-03-12 2024-01-30 Corning, Incorporated Ceramic honeycomb body with skin
TWI803052B (en) * 2021-11-12 2023-05-21 佛教慈濟醫療財團法人 Transdermal delivery device, methods of using and making the same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3634016A1 (en) * 1986-04-17 1987-10-29 Lohmann Gmbh & Co Kg AREA-BASED THERAPEUTIC SYSTEM, METHOD FOR THE PRODUCTION THEREOF AND ITS USE
US5503844A (en) * 1993-05-18 1996-04-02 Mli Acquisition Corp. Ii Foam laminate transdermal patch
FR2719220A1 (en) * 1994-04-29 1995-11-03 Lafon Labor New galenic form for transdermal administration.
DE69524614T2 (en) * 1994-10-05 2002-09-12 Hisamitsu Pharmaceutical Co MEDICINAL COMPONENTS, INCLUDING AN N-SUBSTITUTED O-TOLUIDE INDEXIVATIVE AND TRANSDERMALLY ABSORBABLE PREPARATION
DE19541260A1 (en) * 1995-11-06 1997-05-07 Lohmann Therapie Syst Lts Therapeutic preparation for transdermal application of active ingredients through the skin
AU1143899A (en) * 1997-11-10 1999-05-31 Novo Nordisk A/S Transdermal delivery of 3,4-diarylchromans

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8173155B2 (en) 2004-06-01 2012-05-08 Hisamitsu Pharmaceutical Co., Inc. Adhesive patch

Also Published As

Publication number Publication date
KR20010079513A (en) 2001-08-22
HUP0102718A2 (en) 2002-03-28
JP2002520272A (en) 2002-07-09
HU226614B1 (en) 2009-04-28
EP1094797B1 (en) 2004-10-06
CZ200193A3 (en) 2001-05-16
DE19830732A1 (en) 2000-01-13
CZ300976B6 (en) 2009-09-30
PL194983B1 (en) 2007-07-31
NZ509215A (en) 2003-04-29
AR019902A1 (en) 2002-03-20
TR200100021T2 (en) 2001-05-21
AU5157499A (en) 2000-02-01
CA2336712C (en) 2008-09-09
PL345510A1 (en) 2001-12-17
DE19830732B4 (en) 2008-11-13
ES2230872T3 (en) 2005-05-01
CN1309377C (en) 2007-04-11
TWI237572B (en) 2005-08-11
KR100549848B1 (en) 2006-02-06
IL140667A0 (en) 2002-02-10
IL140667A (en) 2007-05-15
BR9911941A (en) 2001-03-27
CN1308525A (en) 2001-08-15
ATE278395T1 (en) 2004-10-15
EP1094797A1 (en) 2001-05-02
RU2227023C2 (en) 2004-04-20
AU770573B2 (en) 2004-02-26
HUP0102718A3 (en) 2002-12-28
DE59910758D1 (en) 2004-11-11
WO2000002541A1 (en) 2000-01-20
ZA200100171B (en) 2001-08-10
MXPA01000126A (en) 2002-06-04

Similar Documents

Publication Publication Date Title
CA2336712A1 (en) Transdermal plaster containing at least one active ingredient which influences blood serum lipid levels
CA2302601A1 (en) Transdermal therapeutic system comprising a reservoir-type pressure-sensitive adhesive layer and a back layer with uni-directional resilience
EP0387751A3 (en) Medicated plasters
MY100066A (en) Multicompartmentalized dermal and transdermal patches.
AU594805B2 (en) Means for the application of transdermally absorbable active susbstances
IE800059L (en) Polymeric diffusion matrix
HK94093A (en) Adhesive transdermal dosage layer
CA2276445A1 (en) Transdermal hormone-delivering therapeutic system
AU6957498A (en) Methods of diagnosing clinical subtypes of crohn's disease with characteristic responsiveness to anti-th1 cytokine therapy
NO951523L (en) Plastics for transdermal administration of volatile, pharmaceutically active, chemically basic constituents, as well as process for the preparation of the patch
EP0862924A3 (en) Medical electrode device easily removed from skin and a method of removal therefrom
MY103355A (en) Active substance-containing plaster of the controlled administration of active substances to the skin, the use thereof and a process for the controlled administration of active substances to the skin
IL106512A (en) Plaster for the transdermal application of steroid hormones and process for the preparation thereof
CA2387143A1 (en) Transdermal therapeutic system containing tulobuterol hydrochloride for administering the bronchodilator tulobuterol via the skin
EP0664119A3 (en) Tape transdermal use easily detachable from the skin
CA2278639A1 (en) Transdermal or topical plaster system with a polyacrylate matrix with improved physical properties
CA2007353A1 (en) Superficial Therapeutic System Comprising an Antineoplastic Active Substance, Particularly 5-Fluorouracil
ATE283041T1 (en) PATCH FOR TRANSDERMAL THERAPY
CA2300339A1 (en) Transdermal therapeutic system containing the active substance scopolamine base
AU715763B2 (en) Surface-stabilised pharmaceutical preparation for skin application
AU3258395A (en) Estradiol-TTS having water-binding additives
GR3002566T3 (en) Dermal and transdermal therapeutic system having a discontinuous-pattern adhesive layer and method of manufacturing thereof
AU2649288A (en) Transdermal absorptive drug formulation
SI0859595T1 (en) Therapeutic preparation for the transdermal administration of active substances
CA1269326C (en) Adhesive transdermal dosage layer

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20190708